Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 16/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KLK7 | P49862 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | UBE2N | P61088 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23589255 | 0.74 | HTR6 (0.55) | HTR6CYP3A4CYP2D6L3MBTL1KLK7 | |
| SCHEMBL31571431 | 0.74 | HTR6 (0.55) | HTR6CYP3A4CYP2D6L3MBTL1KLK7 | |
| SCHEMBL28632664 | 0.73 | L3MBTL1 (0.46) | HTR6CYP3A4CYP2D6L3MBTL1KLK7 | |
| SCHEMBL28508667 | 0.73 | PTPN11 (0.46) | HTR6 | |
| SCHEMBL1612680 | 0.70 | HTR6 (0.50) | HTR6CYP3A4CYP2D6L3MBTL1KLK7 | |
| SCHEMBL8483886 | 0.69 | HTR6 (0.66) | HTR6CYP3A4CYP2D6 | |
| SCHEMBL19611706 | 0.69 | HTR6 (0.49) | HTR6CYP3A4CYP2D6L3MBTL1KLK7 | |
| SCHEMBL28506377 | 0.69 | PTPN11 (0.45) | HTR6CYP3A4CYP2D6L3MBTL1 | |
| SCHEMBL945912 | 0.68 | KDM4E (0.67) | HTR6CYP3A4CYP2D6L3MBTL1KLK7 | |
| SCHEMBL6805163 | 0.68 | HTR6 (0.45) | HTR6CYP3A4CYP2D6L3MBTL1KLK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112243439-A | Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof | 百济神州有限公司 | 2021-01-19 | — | — | CN | disclosed |